Lataa...
Post-transcriptional regulation of ERBB2 by miR26a/b and HuR confers resistance to tamoxifen in estrogen receptor-positive breast cancer cells
Tamoxifen-resistant (TAMR) estrogen receptor-positive (ER+) breast cancer is characterized by elevated Erb-B2 receptor tyrosine kinase 2 (ERBB2) expression. However, the underlying mechanisms responsible for the increased ERBB2 expression in the TAMR cells remain poorly understood. Herein, we report...
Tallennettuna:
Julkaisussa: | J Biol Chem |
---|---|
Päätekijät: | , , , , , , , , , , , , , , , , , , , |
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
American Society for Biochemistry and Molecular Biology
2017
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5566515/ https://ncbi.nlm.nih.gov/pubmed/28637868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M117.780973 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|